Pharmacokinetics and metabolism of medroxyprogesterone acetate. Influence of the route of administration and of its physical state.

E. Castegnaro,G. Sala
Abstract:To clarify the role of the pharmaceutical preparation of 6 alpha methyl-17-alpha-acetoxyprogesterone (MAP) metabolism and to study the pharmacokinetics of this steroid in humans MAP was administered under different conditions in the same subjects and the metabolism of MAP after administration of radioactive material was studied. MAP (50 or 100 mg) was administered orally (po) or intramuscularly (im) in aqueous suspension or in oily solution. A single dose of 12 or 50 mCi tritiated MAP was administered to 5 of the subjects and total radioactivity and radioactivities estractable without hydrolysis and after hydrolysis with beta-glycuronidase were measured. In aqueous suspension of MAP delayed and reduced the urinary excretion of metabolites. Administration of MAP po or im in oily solution caused a strong increase of Porter-Silber metabolites. After tritiated MAP po the radioactivity measured was mostly due to conjugated metabolites. Traces of radioactivity remained up to 31 days after injection but most was excreted within 24 hours when given po. It was suggested that the route of administration (po) and the physical state of MAP (oily solution) favor a more prompt metabolism and urinary excretion of the steriod and that these factors influence the metabolic fate.
What problem does this paper attempt to address?